← Leaderboards
Qiang Zhang
Parkside Scientific, Inc.
$299,760
Attributed
$599,519
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2017–19$500K$375K$250K$125K$0
'17
'18
'19
Funding mix
By agency
NIH$599,519 · 2
By mechanism
R43$599,519 · 2
Top collaborators
- Ming-Ming Zhou2 shared
Others in their field
Other Emerging Leaders on “Immunomodulators”
- Crystal Mackall · Children'S Hosp Of Philadelphia$10,785,733
- Gary Fanger · Rise Therapeutics, Llc$9,167,950
- Julie E Bauman · University Of Arizona$4,745,397
- Kathleen Engelman · Univ Of Massachusetts Med Sch Worcester$4,659,022
- Diogo Magnani · Univ Of Massachusetts Med Sch Worcester$4,659,022
- Kristopher Paolino · Icon Government And Public Health Solutions, Inc.$4,299,774
Research focus
ImmunomodulatorsNew Therapeutic TargetCytokineGenetic TranscriptionInterleukin-17MedicalCellsClinical TrialsDesignEpigenetic ProcessInflammationInflammatoryIn VivoLeadCd4 Positive T LymphocytesCell Differentiation ProcessAutomobile DrivingChemical AgentsAnimalsBaseDrug CandidateDrug KineticsAffectNext Generation